NCT00548197View on ClinicalTrials.gov

Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Intravitreal Bevacizumab InjectionPars Plana VitrectomyTractional Retinal DetachmentDiabetic Retinopathy
Interventions
DRUG

Bevacizumab

one intravitreal injection of 2.5 mg Bevacizumab 3-5 days before performing pars plana vitrectomy

Trial Locations (1)

14455-364

Rasool Akram Hospital, Tehran

All Listed Sponsors
lead

Iran University of Medical Sciences

OTHER

NCT00548197 - Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment | Biotech Hunter | Biotech Hunter